![hero image](/_next/image?url=%2Fimages%2FCRLogo.png&w=384&q=75)
Text Registration
Copyright Title
The Future of RA Treatment With JAK Inhibitors
Status
Published
on 30 Jan 2019
Year of Creation
2018
Copyright Claimant
Med-IQ, Inc
Registration Number
TX0008699841
on 30 Jan 2019Copyright Summary
The U.S. Copyright record (Registration Number: TX0008699841) dated 30 Jan 2019, pertains to an electronic file (eService) titled "The Future of RA Treatment With JAK Inhibitors" created in 2018. The copyright holder is Med-IQ, Inc, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Med-IQ, Inc.
Application Details
Registration Number
TX0008699841
Registration Date
1/30/2019
Year of Creation
2018
Agency Marc Code
DLC-CO
Record Status
New
Corporate Author
Med-IQ, Inc
Physical Description
Electronic file (eService)
First Publication Nation
United States
Preexisting Material
References
Notes
Rights Note: Susan Dembeck, Med-IQ, Inc., 5523 Research Park Drive, Ste 210, Baltimore, MD, 21228, United States, (443) 543-5114, sdembeck@med-iq.com
Material Matter Claimed Note: text
Statements
Application Title Statement: The Future of RA Treatment With JAK Inhibitors
Author Statement: Med-IQ, Inc employer for hire Domicile: United States Citizenship: United States Authorship: text
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.